High SARS-CoV-2 seroprevalence in Karaganda, Kazakhstan before the launch of COVID-19 vaccination

High SARS-CoV-2 seroprevalence in Karaganda, Kazakhstan before the launch of COVID-19 vaccination

COVID-19 exposure in Central Asia appears underestimated and SARS-CoV-2 seroprevalence data are urgently needed to inform ongoing vaccination efforts and other strategies to mitigate the regional pandemic. Here, in a pilot serologic study we assessed the prevalence of SARS-CoV-2 antibody-mediated im...

Full description

Bibliographic Details
Main Authors: Irina Kadyrova, Sergey Yegorov, Baurzhan Negmetzhanov, Yevgeniya Kolesnikova, Svetlana Kolesnichenko, Ilya Korshukov, Lyudmila Akhmaltdinova, Dmitriy Vazenmiller, Yelena Stupina, Naylya Kabildina, Assem Ashimova, Aigul Raimbekova, Anar Turmukhambetova, Matthew S. Miller, Gonzalo Hortelano, Dmitriy Babenko
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328563/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328563/?tool=EBI

Similar Items